Cargando…
From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of CYP2C19
Background: Inter-individual differences in drug response based on genetic variations can lead to drug toxicity and treatment inefficacy. A large part of this variability is caused by genetic variants in pharmacogenes. Unfortunately, the Single Nucleotide Variant arrays currently used in clinical ph...
Autores principales: | Graansma, Lonneke J., Zhai, Qinglian, Busscher, Loes, Menafra, Roberta, van den Berg, Redmar R., Kloet, Susan L., van der Lee, Maaike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014917/ https://www.ncbi.nlm.nih.gov/pubmed/36937863 http://dx.doi.org/10.3389/fphar.2023.1076574 |
Ejemplares similares
-
Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
por: Zhai, Qinglian, et al.
Publicado: (2022) -
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
por: Del Tredici, Andria L., et al.
Publicado: (2018) -
Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells
por: Du, Huihui, et al.
Publicado: (2016) -
Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro
por: Zhou, Xiao-Yang, et al.
Publicado: (2019) -
Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing
por: Turner, Amy J., et al.
Publicado: (2023)